Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Soundbites Public Benefit Corporation (PBC) is an applied biomedical auditory neuroscience company focused on hearing preservation and the prevention of sensorineural hearing loss (SNHL). Founded as a spinout from the University of Michigan Medical School's Kresge Hearing Research Institute, the company commercializes the ACEMg formula, a patented combination of vitamins A, C, E, and magnesium designed to protect inner ear hair cells from oxidative stress and metabolic exhaustion. Its flagship product, marketed as Soundbites, is a biomedicine clinically proven to preserve or improve inner ear function and sensitivity. The company actively conducts large-scale real-world evidence studies, such as the OTIS Study, to further validate its impact on tinnitus, hyperacusis, and cognitive health.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Soundbites.